Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma

ID
Name
Zia ud din university karachi
Description
COMPARISON OF EFFICACY OF HYDROCORTISONE AND METHYLPREDNISOLONE IN ACUTE SEVERE ASTHMA In this study Investigator will compare the efficacy of hydrocortisone and methyl prednisolone in acute severe asthma that will lead to final result and beneficial effects that will help in early resoloution of symptoms and help in preventing recurrence
Trial arms
Trial start
2023-11-26
Estimated PCD
2024-08-01
Trial end
2024-08-08
Treatment
Methylprednisolone,
No intervention required
Arms:
METHYLPREDNISOLONE
Other names:
Hydrocortisone
Size
60
Primary endpoint
Spirometry
24 hours
Blood pressures
24 hours
Respiratory rate
24 hours
Heart rate
24 hours
PEAK EXPIRATORY FLOW RATE
24 hours
Eligibility criteria
Inclusion Criteria: * Either Gender (18 to 50 years old) * Patient presenting to emergency department with acute severe asthma Exclusion Criteria: * Patients with critical illness or pregnant females. .Patient treated other than hydrocortisone and methylprednisolone. .Patients not willing to participate in study. * Life threatening asthma * Near fatal asthm
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': True, 'targetDuration': '2 Days', 'designInfo': {'observationalModel': 'ECOLOGIC_OR_COMMUNITY', 'timePerspective': 'CROSS_SECTIONAL'}, 'enrollmentInfo': {'count': 60, 'type': 'ESTIMATED'}}
Updated at
2023-12-15

1 organization

1 product

1 indication

Organization
University of Karachi
Product
Methylprednisolone,
Indication
Asthma